This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

National Research Corporation Announces New Board Of Directors Member

LINCOLN, Neb., June 2, 2014 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA and NRCIB) announced the election of Barbara Mowry as the newest member of the Board of Directors, effective immediately. Mowry will be an active member of the company's audit, compensation, strategic planning, and nominating committees. Mowry is Chief Executive Officer of GoreCreek Advisors, a privately held management consulting firm focused on working with CEOs and boards on business strategy and innovation. Prior to this, she was Senior Vice President of Data Integration at Oracle Corporation, an industry leading software, hardware, and services company. From 2003 to 2009 she served as CEO, President, and board member for Silver Creek Systems, Inc., a privately held venture capital funded software company where she was awarded technology patents and recognized as a market leader by major technology analyst firms, including Gartner and Forrester. Her extensive corporate background also includes CEO positions in four firms and holding executive leadership positions in three Fortune 500 companies, including United Airlines, TCI (Comcast), and Oracle Corporation. Mowry is an experienced board member and currently serves on several boards, including Chairman of the Board of Directors for the Federal Reserve Bank of Kansas City; board of trustees member for the Kauffman Foundation; board member for the Carlson School of Management; and is a board member of the Colorado Chapter of the National Association of Corporate Directors (NACD) and a NACD Leadership Fellow. In 2011, Mowry was named to the "International 100 Top Board Candidates with Global Skills," a Financial Times publication for board members. In 2010, she was named as "The Outstanding Woman in Business in Technology and Telecommunications" by the Denver Business Journal. Mowry is a graduate of Miami University and received an MBA from the University of Minnesota. About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA and NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. Recognized by Modern Healthcare as the largest patient satisfaction firm in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to info@nationalresearch.com, or visit www.nationalresearch.com .

CONTACT: Media Contact:
         Scott Smith
         Director of Marketing
         National Research Corporation
         800-388-4264
         scsmith@nationalresearch.com 
         
         Investor Contact: 
         Kevin Karas
         Chief Financial Officer
         National Research Corporation
         800-388-4264
         kkaras@nationalresearch.com

National Research Corporation Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs